Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus Article

Kabir, Md Tanvir, Mitu, Jannatul Ferdous, Akter, Raushanara et al. (2022). Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus . ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 29(31), 46385-46404. 10.1007/s11356-022-20445-1

International Collaboration

cited authors

  • Kabir, Md Tanvir; Mitu, Jannatul Ferdous; Akter, Raushanara; Akhtar, Muhammad Furqan; Saleem, Ammara; Al-Harrasi, Ahmed; Bhatia, Saurabh; Rahman, Md Sohanur; Damiri, Fouad; Berrada, Mohammed; Rahman, Md Habibur

publication date

  • July 1, 2022

keywords

  • BODY-FAT STORES
  • BROMOCRIPTINE MESYLATE
  • Bromocriptine
  • CARDIOVASCULAR-DISEASE
  • Cabergoline
  • Dopamine agonist
  • Environmental Sciences
  • Environmental Sciences & Ecology
  • GLUCOSE-TOLERANCE
  • IMPROVE GLYCEMIC CONTROL
  • INSULIN-RESISTANCE
  • INTIMA-MEDIA THICKNESS
  • Life Sciences & Biomedicine
  • PHYSICAL-ACTIVITY
  • RISK-FACTORS
  • SUPRACHIASMATIC NUCLEI
  • Science & Technology
  • Triglycerides
  • Type 2 diabetes

Digital Object Identifier (DOI)

publisher

  • SPRINGER HEIDELBERG

start page

  • 46385

end page

  • 46404

volume

  • 29

issue

  • 31